These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26330159)

  • 1. Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration.
    Pawar H; Wankhade SR; Yadav DK; Suresh S
    Pharm Dev Technol; 2016 Sep; 21(6):725-36. PubMed ID: 26330159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach.
    Yadav DK; Pawar H; Wankhade S; Suresh S
    AAPS PharmSciTech; 2015 Aug; 16(4):855-64. PubMed ID: 25583303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.
    Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK
    J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
    Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
    Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
    Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
    Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
    Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
    Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
    J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.
    Bu X; Zhu T; Ma Y; Shen Q
    Drug Dev Ind Pharm; 2015 May; 41(5):764-71. PubMed ID: 24669977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
    Qu G; Wu X; Yin L; Zhang C
    Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
    Jain S; Bhankur N; Swarnakar NK; Thanki K
    Pharm Res; 2015 Oct; 32(10):3282-92. PubMed ID: 25968624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres of curcumin for treatment of inflammation.
    Kumar V; Lewis SA; Mutalik S; Shenoy DB; Venkatesh ; Udupa N
    Indian J Physiol Pharmacol; 2002 Apr; 46(2):209-17. PubMed ID: 12500496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy.
    Balakrishnan P; Song CK; Jahn A; Cho HJ
    Pharm Res; 2016 Jan; 33(1):206-16. PubMed ID: 26337769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated poly(anhydride) nanoparticles for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Larrañeta E; Reviakine I; Yate LA; Irache JM
    Eur J Pharm Sci; 2018 Jun; 118():165-175. PubMed ID: 29597043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
    Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.